-
Decision Time: The Cheshire Cat Method or STEM for a Net Zero Carbon Future?
This is now Article 5 of the Net Zero Carbon series. In Articles 1 through 4 (“Net Zero…
-
Rare Earths, “The War Metals?”
Sometime after 2007, I was invited to participate in a meeting called by the Office of Net Threat…
-
Record revenues in 2022 of $27.7 million, Valeo Pharma investment in commercial infrastructure starts to pay off
What a difference a year makes. Last year at this time we were heading into wave something or…
-
It appears American Rare Earths has the right stuff
Last week I wrote an article about a rare earths explorer that had just announced a new President,…
-
Lining up uranium production, Ur-Energy responds to new sale agreements and rising demand
Uranium prices continue to drift higher as demand grows and supply remains both constrained and at risk of…
-
Bundeep Singh Rangar of Fineqia International talks about bringing innovation to the digital asset economy
In this InvestorIntel interview, Tracy Weslosky talks to Fineqia International Inc.’s (CSE: FNQ) CEO and Director Bundeep Singh Rangar about how…
-
Economy of Scale – A Misused Metric in Mining
I was surprised earlier this week to see an article in the Wall Street Journal in which the…
-
David Elsley of Cardiol Therapeutics talks about their global Phase II clinical trials for the treatment of heart diseases
In this InvestorIntel interview, Chris Thompson talks to Cardiol Therapeutics Inc.’s (NASDAQ: CRDL | TSX: CRDL) CEO, President and…
-
David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies
In this InvestorIntel interview, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David Regan provides Tracy Weslosky with…
